These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35987109)

  • 1. Fatal neuromyelitis optica after COVID-19 vaccination.
    Boldrini VO; Yasuda CL
    Mult Scler Relat Disord; 2022 Dec; 68():104089. PubMed ID: 35987109
    [No Abstract]   [Full Text] [Related]  

  • 2. Aquaporin-4 IgG neuromyelitis optica spectrum disorder onset after Covid-19 vaccination: Systematic review.
    Harahsheh E; Callister M; Hasan S; Gritsch D; Valencia-Sanchez C
    J Neuroimmunol; 2022 Dec; 373():577994. PubMed ID: 36332464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fulminant neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccination: A need for reconsideration?
    Motahharynia A; Naghavi S; Shaygannejad V; Adibi I
    Mult Scler Relat Disord; 2022 Oct; 66():104035. PubMed ID: 35858498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe disease exacerbation after mRNA COVID-19 vaccination unmasks suspected multiple sclerosis as neuromyelitis optica spectrum disorder: a case report.
    Lohmann L; Glaser F; Möddel G; Lünemann JD; Wiendl H; Klotz L
    BMC Neurol; 2022 May; 22(1):185. PubMed ID: 35585528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic neuromyelitis after vaccination against SARS-CoV-2.
    Hernandez-Vega M; Orozco-Narvaez A; Reyes-Vaca JG; Rodriguez-Leyva I
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36574993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First manifestation of AQP4-IgG-positive neuromyelitis optica spectrum disorder following the COVID-19 mRNA vaccine BNT162b2.
    Umezawa S; Ioka K; Aizawa S; Tashiro Y; Yoshizawa K
    Neurol Sci; 2023 Feb; 44(2):451-455. PubMed ID: 36289118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations.
    Kim KH; Kim SH; Park NY; Hyun JW; Kim HJ
    Mult Scler Relat Disord; 2022 Dec; 68():104141. PubMed ID: 36037757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Watch out for neuromyelitis optica spectrum disorder after inactivated virus vaccination for COVID-19.
    Chen S; Fan XR; He S; Zhang JW; Li SJ
    Neurol Sci; 2021 Sep; 42(9):3537-3539. PubMed ID: 34189662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of neuromyelitis optica spectrum disorder following seasonal influenza vaccination.
    Cho JH; Park Y; Woo N
    Mult Scler Relat Disord; 2019 May; 30():110-113. PubMed ID: 30769255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kong L; Wang X; Chen H; Shi Z; Lang Y; Zhang Y; Zhou H
    Mult Scler Relat Disord; 2022 Dec; 68():104167. PubMed ID: 36170773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment: Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
    Farrell RA
    Neurology; 2012 Jul; 79(3):287. PubMed ID: 22722623
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuromyelitis optica after Japanese encephalitis vaccination.
    Furukawa Y; Komai K; Yamada M
    Eur J Neurol; 2011 Feb; 18(2):e26-e27. PubMed ID: 20825468
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuromyelitis optica complicating COVID vaccinations.
    Finsterer J
    Mult Scler Relat Disord; 2022 Jun; 62():103809. PubMed ID: 35461056
    [No Abstract]   [Full Text] [Related]  

  • 14. Vaccination in neuromyelitis optica spectrum disorders: Friend or enemy?
    Cai H; Zhou R; Jiang F; Zeng Q; Yang H
    Mult Scler Relat Disord; 2022 Feb; 58():103394. PubMed ID: 35216775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Author's response to the commentary: Neuromyelitis optica complicating COVID vaccinations and additional case reports.
    Tisavipat N; Anamnart C; Owattanapanich W; Apiwattanakul M; Savangned P; Prayoonwiwat N; Siritho S; Rattanathamsakul N; Jitprapaikulsan J
    Mult Scler Relat Disord; 2022 Oct; 66():104055. PubMed ID: 35843141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent optic neuritis and neuromyelitis optica-IgG following first and second human papillomavirus vaccinations.
    Chang H; Lee HL; Yeo M; Kim JS; Shin DI; Lee SS; Lee SH
    Clin Neurol Neurosurg; 2016 May; 144():126-8. PubMed ID: 27046292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromyelitis optica following human papillomavirus vaccination.
    Menge T; Cree B; Saleh A; Waterboer T; Berthele A; Kalluri SR; Hemmer B; Aktas O; Hartung HP; Methner A; Kieseier BC
    Neurology; 2012 Jul; 79(3):285-7. PubMed ID: 22722628
    [No Abstract]   [Full Text] [Related]  

  • 18. Humoral response to SARS-CoV-2 infection and vaccines against COVID-19 in patients with neuromyelitis optica spectrum disorders: Impact of immunosuppressive treatment.
    Jovicevic V; Ivanovic J; Momcilovic N; Andabaka M; Tamas O; Veselinovic N; Cujic D; Gnjatovic M; Mesaros S; Pekmezovic T; Drulovic J
    Mult Scler Relat Disord; 2022 Jun; 62():103794. PubMed ID: 35421782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder.
    Mealy MA; Cook LJ; Pache F; Velez DL; Borisow N; Becker D; Arango JAJ; Paul F; Levy M
    Mult Scler Relat Disord; 2018 Jul; 23():78-82. PubMed ID: 29783157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD.
    Dinoto A; Sechi E; Ferrari S; Gajofatto A; Orlandi R; Solla P; Maccabeo A; Maniscalco GT; Andreone V; Sartori A; Manganotti P; Rasia S; Capra R; Mancinelli CR; Mariotto S
    Mult Scler Relat Disord; 2022 Feb; 58():103424. PubMed ID: 35216793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.